newsfilter
← Latest News
GlobeNewswire·

Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market

Vancouver, Canada, July 20, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. ("Clearmind") (NASDAQ:CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogen-derived treatments